Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.

Zhang C, Liu X, Jin S, Chen Y, Guo R. · 2022

Read Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. by Zhang C, Liu X, Jin S, Chen Y, Guo R. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8840702.txt.

Description

Zhang and co-authors review ferroptosis as a way to break cancer drug resistance. Ferroptosis is a form of cell death driven by iron. It differs from apoptosis, necrosis, and autophagy. It also helps suppress tumors. Resistant cancers, though, often dodge standard treatments. Forcing ferroptosis may corner them again. The review tests that idea therapy by therapy.

The authors first explain how ferroptosis works inside the cell. They describe the redox imbalance at its core. They name GPX4 as a central guard against it. They then review chemotherapy and targeted therapy cases. Immunotherapy resistance gets its own treatment. In each case, triggering ferroptosis restored drug effect in studies cited. The authors close with prospects and challenges. Clinical use, they note, is still ahead.

Catalog record

CREATORZhang C, Liu X, Jin S, Chen Y, Guo R.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8840702

Browse the full library · About the Tower of Babel